Novo Nordisk targets five-plus blockbuster launches by 2030
CEO Mike Doustdar said at a Capital Markets Day in London that Novo Nordisk aims to launch more than five blockbuster drugs by 2030, and to deliver more than 150 billion Danish crowns (about $23 billion) in pipeline sales in 2035.